Frontlight ResearchEarly access
Lung cancer trials in United States
900 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peoplePeptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC
- Where
- Baltimore
- Age
- 18 years and over
- People
- 12
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT05950139 - Phase 2Taking peopleStudy of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
- Where
- Detroit
- Age
- 18 years and over
- People
- 35
- Run by
- Bindu R Potugari
See details and how to joinNCT07339059 - Phase 2Taking peopleA Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer
- Where
- Omaha, Seattle
- Age
- 18 years and over
- People
- 40
- Run by
- University of Washington
See details and how to joinNCT05242965 - Phase 1Taking peopleStudy of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer
- Where
- Boston, Nashville, Peoria
- Age
- 18 years and over
- People
- 10
- Run by
- Nerviano Medical Sciences
See details and how to joinNCT06931626 - Phase 2Taking peopleDAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Where
- Baltimore, Boston, Indianapolis, Jacksonville, Lexington, Los Angeles, Miami, Mobile, New York, Phoenix, Richmond, Rochester, San Francisco, Tampa, The Bronx, Westwood
- Age
- 18 years and over
- People
- 204 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT05882058 · EU 2023-504247-13-00 - No phaseTaking peopleThe Florida ASCENT Study
- Where
- Gainesville
- Age
- 18 years to 100 years
- People
- 100
- Run by
- University of Florida
See details and how to joinNCT07042243 - Phase 1Taking peoplePersonalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
- Where
- Seattle
- Age
- 18 years and over
- People
- 28
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT05098210 - Phase 1Taking peopleClinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
- Where
- Baltimore, Columbus, Fairfax, Houston, Lexington, Louisville
- Age
- 18 years and over
- People
- 320 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT05142189 · EU 2023-509283-14-00 - Phase 1Taking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Birmingham, Cleveland, Dallas, Detroit, Fairfax, Farmington Hills, Fort Worth, Houston, Iowa City, Irvine, Orange, Richardson, Sacramento, San Antonio, West Valley City
- Age
- 18 years and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - Phase 1Taking peopleA Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Where
- Aurora, Baltimore, Boston, Duarte, Grand Rapids, Houston, Irving, Kansas City, Nashville, Orlando, Phoenix, Rochester, Salt Lake City, San Antonio, Scottsdale, West Valley City
- Age
- 18 years and over
- People
- 914 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00 - Phase 1Taking peopleA Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- Where
- Baltimore, Boston, Denver, Hackensack, Houston, Nashville, New York, Palo Alto, Philadelphia, Phoenix, Santa Monica, Sarasota
- Age
- 18 years and over
- People
- 710 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06179160 · EU 2023-507091-47-00 - Phase 2Taking peoplectDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer
- Where
- Miami
- Age
- 18 years and over
- People
- 30
- Run by
- University of Miami
See details and how to joinNCT06902272 - No phaseNot yet taking people in United StatesDissemination Of Lung Cancer Screening Education Through Tobacco Quitlines
- Where
- Houston
- Age
- 18 years and over
- People
- 650
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07720141 - Phase 1/2Taking peopleNeoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
- Where
- New York
- Age
- 18 years and over
- People
- 21
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT06088771 - No phaseTaking peopleDigital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics
- Where
- Salt Lake City
- Age
- 50 years to 80 years
- People
- 800
- Run by
- University of Utah
See details and how to joinNCT07716280 - No phaseEnrolling by invitationPilot Testing a Web-based Prototype of a Lung Cancer Screening Digital Health Tool
- Where
- New Brunswick
- Age
- 50 years to 80 years
- People
- 500
- Run by
- Rutgers, The State University of New Jersey
See details and how to joinNCT07716527 - No phaseTaking peopleStudy Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer
- Where
- Rochester
- Age
- 18 years and over
- People
- 100
- Run by
- University of Rochester
See details and how to joinNCT03706027 - Phase 1Taking peopleA Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
- Where
- Columbus, Dallas, Hackensack, Houston, Los Angeles
- Age
- 18 years and over
- People
- 240 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06476808 · EU 2025-523067-38-01 - Phase 2Taking peopleReducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance
- Where
- Winston-Salem
- Age
- 18 years and over
- People
- 60
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT05692635 - Phase 1/2Taking peopleTrial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
- Where
- Orange
- Age
- 18 years and over
- People
- 67
- Run by
- University of California, Irvine
See details and how to joinNCT07064018 - No phaseTaking peoplePCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing
- Where
- Galveston, Houston
- Age
- 55 years to 80 years
- People
- 620
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT02282969 - Phase 2Taking peopleOlanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
- Where
- Portland
- Age
- 18 years and over
- People
- 66
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT05705492 - Phase 1Taking peopleRole of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 800
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03819296 - Phase 1/2Taking peopleA Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- Where
- Baltimore, Boston, Chapel Hill, Denver, Duarte, Durham, Fairfax, Los Angeles, New Haven, Oklahoma City, Portland, San Antonio, Seattle, St Louis
- Age
- 18 years and over
- People
- 203
- Run by
- Phanes Therapeutics
See details and how to joinNCT05652686 - Phase 2Taking peopleIvonescimab Alone And With Carboplatin/Pemetrexed For NSCLC
- Where
- Boston
- Age
- 18 years and over
- People
- 46
- Run by
- Massachusetts General Hospital
See details and how to joinNCT07405190